If Th1 or Th2 polarization could be artificially manipulated, effective immune responses would be generated depending on nature of the targets. In this study we attempted to regulate CD40 expressions on dendritic cells (DCs) in order to modify the T cell response. It was found that reducing agents selectively inhibited surface expression of CD40 on DCs. This finding may provide a new strategy of DC-mediated modulation of the Th1/Th2 balance. It was also shown that NKT-produced Th1/Th2 cytokine balance was under control of negative feedback loop through DCs. Th1 cytokine-pretreated DCs mainly induced Th2 cytokine production, whereas Th2 cytokine-pretreated DCs induced Th1 cytokine production by α-galactosylceramide-stimulated NKT cells. The negative feedback regulation system could be applicable to therapeutics of various diseases based on immunological disorders. 
Introduction
Immunological responses can be divided into two types, T helper 1 (Th1) and Th2. In the Th1 system, interferon (IFN)-γ, interleukin (IL-2) and tumor necrosis factor (TNF)-αplay a major role in protective immunity against viruses, bacteria and tumors (Table 1) . However, the Th1 immunity sometimes aggravates certain types of autoimmune diseases and athrosclerosis (1) (2) (3) . On the other hand, IL-4, IL-10 and IL-13 play a role in Th2 type immunity. The Th2 system is important in anti-parasite reaction, and regulates autoimmune diseases, but aggravates allergy (4, 5) .
Naive T cells differentiate into Th1 or Th2 cells, which are influenced by the environmental condition around these helper T cells. For instance, IL-12 produced by dendritic cells (DCs) promotes Th1 differentiation (6), whereas IL-4 produced by Th2 cells favors induction of Th2 cells in an autocrine manner and establishes Th2 polarization (4, 7) . We also reported that TNF-α enhanced preference of DCs for Th2 differentiation (8). The Th1 or Th2 type determines effectiveness of the response, depending on nature of the targets. Thus, if Th1 or Th2 polarization could be artificially manipulated, we can generate effective responses.
In this brief review we will show a manipulation to regulate CD40 expressions on dendritic cells, which may result in modification of the type of T cell responses (8 -10). Then, we report a novel regulation system governing the Th1/Th2 cytokine balance via DC and natural killer T (NKT) cell interaction (11,12).
Modification of a Costuimulatory Molecule, CD40, on DCs
DCs are most potent antigen presenting cells (13, 14) . Immature DCs vigorously capture antigens ( Fig. 1 ). After stimulation with bacterial products or inflammatory cytokines, these immature DCs maturate. Mature DCs then migrate to lymph nodes in the presence of chemokines, CCL19 and CCL21. These mature DCs express high levels of major Various surface molecules are expressed on DCs (Fig. 3) . These MHC and costimulatory molecules on the DC and T cell antigen receptor (TCR) and costimulatory molecules on the T cell are indispensable for full T cell activation (Fig. 3) . Especially, stimulation of CD40 on the DC by CD40 ligand on the T cell results in promotion of IL-12 production by the DC and Th1 shift. Thus, if CD40 expression on the DCs could be regulated, the Th1 polarization may be prevented.
Reduction of CD40 Expression on DCs
We could successfully established a stable immature DC line (BC1 cells) (18) and, using this cell line, we attempted to reduce the CD40 expression on the DCs. Eventually we found that anti-oxidants such as N-acetyl-L-cysteine (NAC) selectively reduced the expression of CD40 on DCs (9). As shown in Figure 4 , TNF-α upregulated CD80, 86 and 40 and MHC class I and II expressions. When these DCs were further treated with NAC, only CD40 expression was markedly and selectively reduced by the NAC.
The anti-oxidant-mediated reduction of CD40 expression was attributed to the decrease of 5 total CD40 protein in the mature DCs. The TNF-α induced expression of total CD40 protein was significantly reduced by NAC (Fig. 5) . However, no reduction of CD40 mRNA was induced by the NAC. Similar effects were observed when reduced glutathione, a physiological counterpart of NAC, was used to treat DCs (data not shown) (9). These findings suggest that the anti-oxidant affects a post-transcriptional pathway such as translation and/or degradation of CD40 protein.
Cytokine Production of DCs Stimulated through CD40
We then analyzed NK-κB activation and IL-6 and IL-12 productions by DCs stimulated through CD40. In this particular experiment DCs established using aly/aly mice and the aly/+ heterozygotes (C57BL/6 background) were analyzed. Increased levels of phosphorylated p100, an alternative NK-κB pathway member, were seen in mature DCs after stimulation with anti-CD40 monoclonal antibody (mAb) (19) (Fig. 6) . It was also shown in the Figure 6B that the CD40 stimulation induced prominent production of IL-6 and IL-12 in DCs of normal aly/+ heterozygotes. However, the CD40-mediated IL-12 production was very low in DCs of aly/aly mouse. The aly/aly mouse lacks phosphorylation of p100, because of a mutation of NF-κB inducing kinase (20). Thus, these findings suggest that NF-κB pathway is involved in IL-12 production by CD40-stimulated DCs.
In the next experiment we analyzed relationship between activation of p38 MAP kinase and cytokine production in CD40-stimulated DCs (BC1 cells). Treatment with anti-CD40 mAb activated p38 MAPK and induced prominent IL-6 and 12 productions in mature DCs (Fig. 7) as was shown in Figure 6 . It was also demonstrated in Figure 7B that the IL-6, but not IL-12 production was significantly reduced by SB 203580, a p38 MAPK inhibitor. This finding suggests that the p38 MAPK activation is involved in IL-6 but not IL-12 production by mature DCs. From these findings we conclude that IL-6 and IL-12 production by CD40-stimulated 6 mature DCs is controlled by p38 MAPK and NK-κB pathway, respectively (Fig. 8) . Table 2 summarizes the first part of this review. DCs express surface molecules for Ag presentation along with maturation. Especially CD40 is important in Th1 polarization.
DC-Mediate Modification of Immunological Responses (Summary 1)
Reducing agents such as N-acetyl-L-cysteine and reduced glutathione selectively inhibit surface expression of CD40 by regulating the post-transcriptional pathway.
NF-κB activation is involved in the CD40-mediated IL-12 production and p38 MAPK in IL-6 production by mature DCs. Thus, the CD40 stimulation, IL-12 production and Th1 shift story seems not to be that simple. Nevertheless, we consider that these findings may be the basis of DC-mediated modulation of the Th1/Th2 balance. (Fig. 9) . These NKT cells recognize lipid antigens in the context of non-polymorphic CD1d molecules and produce very quickly large amounts of various cytokines upon stimulation (2, 7, 22, 23) . NKT cells kill not only tumor cells but also self immature thymocytes via Fas pathway (24, 25).
A major population of murine NKT cell expresses an invariant Vα chain, Vα14Jα18, paired with a restricted Vβ chains ( 
In Vitro Stimulation of NKT Cells by α-galactosylceramide (α-GalCer)
NKT cells recognize α-GalCer, which is derived from a marine sponge (34), presented by CD1d on DCs and quickly produce a huge amount of IFN-γ and IL-4 ( Fig. 10) . We attempted to modulate DC functions in order to control the type of cytokine production by NKT cells.
Dendritic cells were prepared from BALB/c splenocytes as previously described (11, 18). These CD11c positive DCs were then loaded withα-GalCer for 1 day and treated with IL-4 or IFN-γ for another 3 days. Subsequently, theseα-GalCer-loaded DCs were cultured with nylon-nonadherent splenocytes, a source of NKT cells, from either BALB/c or CD1d knockout (KO) mice of BALB/c background for 48 hours and cytokine levels in the culture supernatant were quantitated by enzyme-linked immnunosorbent assay (ELISA).
As shown in Figure 11A 
Cytotoxic Activity of Splenocytes from IL-4 andα-GalCer-Administered Mice
We next analyzed cytotoxic activity of splenocytes from IL-4C-pretreated mice against various tumor cells 24 hours after α-GalCer administration. It will be seen in Figure 13B that administration ofα-GalCer alone induced considerable cytotoxicity against tumor cells and this α-GalCer-induced cytotoxicity was markedly augmented by the IL-4 pretreatment.
In the last experiment, we evaluated effect of IL-4 pretreatment on theα-GalCer-induced 9 anti-cancer activity using a lung metastasis model. BALB/c mice were pretreated with IL-4C, and 3 days later intravenously injected with renal adenocarcinoma cells together with α-GalCer (Fig. 14) . Three weeks later, the number of lung metastases was counted. Figure 15B shows a representative view of lung metastasis, and Figure 15A shows the mean metastasis number. Treatment withα-GalCer alone markedly inhibited metastasis as previously reported (35, 36, 38) .
It should be noted here that significantly reduced metastases were observed in mice treated with both IL-4 andα-GalCer compared with those in mice treated with α-GalCer alone. No anti-metastatic effect was observed in mice given PBS or IL-4C alone (Fig. 15 ). These findings demonstrate that treatment of mice with IL-4 and α-GalCer markedly enhances IFN-γ production and anti-tumor responses. Figure 16 summarizes the second part of this review. NKT-produced Th1/Th2 cytokine balance is under control of negative feedback loop through DCs. Th1 cytokine-pretreated DCs mainly induced Th2 cytokine production, whereas Th2 cytokine-pretreated DCs induced Th1 cytokine production in NKT cells.
Negative Feedback Regulation between DCs and NKT Cells (Summary 2)
We also showed that in vivo IL-4 pretreatment of mice led to augmented anti-cancer effect by an NKT ligand, α-GalCer. We hope that the negative feedback regulation system with the use of NKT-specific ligands could be applicable to therapeutics of not only cancer, but also various infectious diseases, and autoimmune diseases (5, 11, 23, 39, 40) . 
